Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5117580 | 6139098 | I | 5117580-3 | 20060919 | 20060929 | EXP | FR-ROCHE-463820 | ROCHE | 53 | YR | F | Y | 20060929 | MD | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5117580 | 1007716921 | PS | GANCICLOVIR | 1 | UNKNOWN | SECOND THERAPY. STARTED FIVE DAYS AFTER FIRST THERAPY WAS STOPPED. | 20460 | ||||
| 5117580 | 1007716922 | SS | GANCICLOVIR | 1 | UNKNOWN | 020460 | |||||
| 5117580 | 1007716923 | SS | ARGININE BUTYRATE | 2 | UNKNOWN | DRUG NAME: ARGININE BUTYRATE. ESCALATING DOSE OF LESS THAN OR EQUAL TO 1500 MG/KG. SECOND THERAPY S+ | |||||
| 5117580 | 1007716924 | SS | ARGININE BUTYRATE | 2 | UNKNOWN | DRUG NAME: ARGININE BUTYRATE. ESCALATING DOSE OF LESS THAN OR EQUAL TO 1500 MG/KG. | |||||
| 5117580 | 1007716925 | C | ADRIAMYCIN PFS | 1 | THE PATIENT RECEIVED FOUR CYCLES OF TREATMENT IN COMBINATION WITH CYCLOPHOSPHAMIDE/BLEOMYCIN AND PR+ | ||||||
| 5117580 | 1007716926 | C | CYCLOPHOSPHAMIDE | 1 | THE PATIENT RECEIVED FOUR CYCLES OF TREATMENT IN COMBINATION WITH ADRIAMYCIN, BLEOMYCIN AND PREDNIS+ | ||||||
| 5117580 | 1007716927 | C | BLEOMYCIN | 1 | THE PATIENT RECEIVED FOUR CYCLES OF TREATMENT IN COMBINATION WITH ADRIAMYCIN, CYCLOPHOSPHAMIDE AND + | ||||||
| 5117580 | 1007716928 | C | PREDNISONE TAB | 1 | THE PATIENT RECEIVED FOUR CYCLES OF TREATMENT IN COMBINATION WITH ADRIAMYCIN, CYCLOPHOSPHAMIDE AND + | ||||||
| 5117580 | 1007716929 | C | CISPLATIN | 1 | SECOND LINE CHEMOTHERAPY IN COMBINATION WITH CYTOSINE ARABINOSIDE AND PREDNISOLONE. | ||||||
| 5117580 | 1007716930 | C | CYTOSINE ARABINOSIDE | 2 | SECOND LINE CHEMOTHERAPY IN COMBINATION WITH CYTOSINE ARABINOSIDE AND PREDNISOLONE. | ||||||
| 5117580 | 1007716931 | C | PREDNISOLONE | 1 | SECOND LINE CHEMOTHERAPY IN COMBINATION WITH CYTOSINE ARABINOSIDE AND PREDNISOLONE. |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5117580 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 5117580 | HEPATITIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5117580 | 1007716922 | 12 | DAY | ||
| 5117580 | 1007716924 | 12 | DAY |